Stocks · Healthcare · Medical - Healthcare Information Services
Teladoc Health, Inc. TDOC
$5.79 +4.89% Close, Oct 5, 2026 · NYSE · Market cap $1.00B
High risk
Next earnings report: Oct 28, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Over the past year the stock returned -31.7%, behind the S&P 500 by 47.5 percentage points.
- The stock is 40% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 27%
- FCF growth (TTM, YoY)Bottom 48%
- Revenue growth, 3-year CAGRBottom 28%
- Revenue growth accelerationBottom 46%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 40%
- Gross marginTop 38%
- Operating marginTop 50%
- Accruals (lower is better)Top 20%
- Interest coverBottom 34%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 37%
- Free-cash-flow yieldTop 3%
- EBITDA / enterprise valueBottom 48%
- Sales / enterprise valueTop 4%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 21%
- 6-month returnBottom 50%
- 1-year return vs S&P 500Bottom 22%
- Distance from 52-week highBottom 38%
- Trend checklist (0–4)Bottom 13%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 43%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 5%
- Upside to consensus price targetBottom 46%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 17%
- Maximum drawdown, 3 yearsBottom 33%
- Beta vs S&P 500 (lower is better)Bottom 24%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -1.5% | -2.1% | ↓ |
| Gross margin | 70.3% | 73.5% | ↑ |
| Operating margin | -10.5% | -7.0% | ↑ |
| FCF margin | 8.3% | 9.0% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -2.1% | -1.5% | ↓ | Bottom 27% |
| Gross margin | 73.5% | 70.3% | ↑ | Top 38% |
| Operating margin | -7.0% | -10.5% | ↑ | Top 50% |
| Net margin | -7.1% | -8.2% | ↑ | — |
| Free-cash-flow margin | 9.0% | 8.3% | ↑ | — |
| Return on invested capital | -7.1% | — | Top 40% | |
| Revenue growth, 3-year CAGR | 1.7% | — | Bottom 28% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -15.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +0.7 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -8.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.29%
- Shareholder yield
- -0.29%
- Share count change, 1 year
- +2.4%
- Share count change, 3-year CAGR
- +3.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +7.3%
- Average 2-day reaction, last 8
- -1.8%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $8.83
- Target vs current price
- +52.5%
- Analysts with a rating
- 42
- Share rating Buy or Strong Buy
- 36%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | +15.9% | -1.9% | -28.3% | -33.9% | — |
| Apr 29, 2026 | -5.5% | -0.8% | +11.0% | +9.8% | +46.2% |
| Feb 25, 2026 | +26.3% | +2.4% | +12.3% | +19.4% | +42.7% |
| Oct 29, 2025 | -7.7% | -1.6% | -4.5% | -10.8% | -24.8% |
| Jul 29, 2025 | +29.6% | -8.2% | -15.0% | -6.5% | +5.6% |
| Apr 30, 2025 | -60.6% | -1.9% | -7.5% | -4.9% | +11.9% |
| Feb 26, 2025 | -21.7% | -1.7% | -17.7% | -22.7% | -37.7% |
| Oct 30, 2024 | +32.1% | -0.7% | +2.6% | +27.5% | +17.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | -$0.21 | -$0.25 | +15.9% | $606.9M |
| Apr 29, 2026 | -$0.36 | -$0.34 | -5.5% | $613.8M |
| Feb 25, 2026 | -$0.14 | -$0.19 | +26.3% | $642.3M |
| Oct 29, 2025 | -$0.28 | -$0.26 | -7.7% | $626.4M |
| Jul 29, 2025 | -$0.19 | -$0.27 | +29.6% | $631.9M |
| Apr 30, 2025 | -$0.53 | -$0.33 | -60.6% | $629.4M |
| Feb 26, 2025 | -$0.28 | -$0.23 | -21.7% | $640.5M |
| Oct 30, 2024 | -$0.19 | -$0.28 | +32.1% | $640.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 0.51× | — | — | Top 4% |
| Free-cash-flow yield | 22.40% | — | — | Top 3% |
| Earnings yield | -17.10% | — | — | Bottom 37% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -15.8%
- 200-day average slope (20 days)
- -2.0%
- Distance from 50-day average
- -11.5%
- Distance from 200-day average
- -11.7%
- RSI (14)
- 38.8
- Relative volume
- 1.31×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 81.5%
- Volatility vs own 5-year history
- 87th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.70
- Correlation with S&P 500
- 0.41
- Current drawdown from 1-year high
- -40.4%
- Maximum drawdown, 3 years
- -79.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 8, 2021 | Feb 12, 2026 | -98.5% | 1259 days | Not yet recovered |
| Oct 13, 2020 | Nov 10, 2020 | -25.6% | 20 days | 46 days (Jan 19, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.00B
- EPS, diluted (TTM)
- -$0.99
- Revenue (TTM)
- $2.49B
- 52-week range
- $4.40 – $9.89
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.03B | $2.41B | $2.60B | $2.57B | $2.53B |
| Gross profit | $1.38B | $1.66B | $1.84B | $1.82B | $1.76B |
| Operating income | -$265.6M | -$13.65B | -$248.6M | -$1.02B | -$263.0M |
| Net income | -$428.8M | -$13.66B | -$220.4M | -$1.00B | -$200.3M |
| EPS (diluted) | -$2.73 | -$84.60 | -$1.34 | -$5.87 | -$1.14 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $640.5M | $640.5M | $629.4M | $631.9M | $626.4M | $642.3M | $613.8M | $606.9M |
| Net income | -$33.3M | -$48.4M | -$93.0M | -$32.7M | -$49.5M | -$25.1M | -$63.8M | -$38.9M |
| EPS (diluted) | -$0.19 | -$0.28 | -$0.53 | -$0.19 | -$0.28 | -$0.14 | -$0.36 | -$0.21 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $194.0M | $189.3M | $350.0M | $293.7M | $294.4M |
| Capital expenditure | -$8.5M | -$16.5M | -$156.3M | -$10.8M | -$8.9M |
| Free cash flow | $185.5M | $172.8M | $193.7M | $282.9M | $285.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $42.6M | $12.4M | $11.1M | $8.3M | $3.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $774.3M
- Total assets
- $2.76B
- Total liabilities
- $1.45B
- Total debt
- $1.04B
- Net debt
- $261.9M
- Shareholders’ equity
- $1.31B
As of Jun 30, 2026 (filed Jul 30, 2026).
Short interest
- Shares sold short
- 27,626,898
- Days to cover
- 8.49
- Change vs previous report
- +9.0%
FINRA short interest, settlement date Sep 15, 2026.